发明名称 Compositions of microbiota and methods related thereto
摘要 Methods and compositions are provided for treating weight related conditions and metabolic disorders by altering microbiota in a subject. One aspect provides methods and compositions to alter microbiota in a subject by administering to the subject a composition that includes a substantially purified microbiota from phyla such as Bacteroidetes, Proteobacteria, Firmicutes and Verrucomicrobia or orders such as Bacteroidales, Verrucomicrobiales, Clostridiales and Enterobacteriales or genera such as Alistipes, Clostridium, Escherichia, and Akkermansia. Another aspect includes a pharmaceutical composition for altering microbiota that includes a therapeutically effective amount of substantially purified microbiota and a pharmaceutically acceptable carrier. Yet another aspect includes methods for treating a disorder, such as obesity, in a subject in need of such treatment by changing relative abundance of microbiota in a gastrointestinal tract of the subject without or in addition to a surgical procedure.
申请公布号 US9173910(B2) 申请公布日期 2015.11.03
申请号 US201313780284 申请日期 2013.02.28
申请人 The General Hospital Corporation;Ethicon Endo-Surgery, Inc.;President and Fellows of Harvard College 发明人 Kaplan Lee M.;Liou Alice P.;Turnbaugh Peter J.;Harris Jason L.
分类号 A61K35/74;A61K35/741;A61K45/06;C12Q1/68 主分类号 A61K35/74
代理机构 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. 代理人 Mintz Levin Cohn Ferris Glovsky and Popeo, P.C. ;Geary William C.;Ashraf Shovon
主权项 1. A method of altering relative abundance of microbiota in a subject comprising administering to the subject an effective dose of a composition consisting essentially of substantially purified Verrucomicrobia; wherein the subject has a disorder selected from the group consisting of: obesity, metabolic syndrome, insulin deficiency, insulin-resistance related disorders, glucose intolerance, diabetes, non-alcoholic fatty liver, and abnormal lipid metabolism.
地址 Boston MA US
您可能感兴趣的专利